LifeMD secures $30M revolving credit facility
LifeMD, Inc. entered into a Credit Agreement with Citizens Bank providing a senior secured revolving credit facility of up to $30 million to support potential corporate development and shareholder value initiatives.
Rhea-AI Filing Summary
LifeMD, Inc. entered into a Credit Agreement with Citizens Bank providing a senior secured revolving credit facility of up to $30 million to support potential corporate development and shareholder value initiatives.
The facility may be increased by up to an additional $20 million and matures on January 2, 2029. Interest is variable, based on either Term SOFR plus a margin of 1.50%–2.25% or an Alternate Base Rate plus a margin of 0.50%–1.25%, with a commitment fee of 0.225%–0.30% on unused amounts, all tied to the Consolidated Leverage Ratio.
Key financial covenants require a Consolidated Leverage Ratio at or below 2.50 to 1.00 and a Consolidated Interest Coverage Ratio of at least 3.00 to 1.00, beginning with the quarter ending March 31, 2026. LifeMD had not drawn any funds under the facility as of the January 2, 2026 closing.
Positive
- None.
Negative
- None.
Insights
LifeMD adds undrawn $30M revolver with covenants but no upfront fee.
LifeMD has arranged a senior secured revolving credit facility of up to $30 million, expandable by $20 million, with Citizens Bank. Because the facility was undrawn as of January 2, 2026, it immediately bolsters available liquidity without increasing current debt.
Pricing is tied to market benchmarks, using Term SOFR with a 1.50%–2.25% margin or an Alternate Base Rate with a 0.50%–1.25% margin, plus a 0.225%–0.30% commitment fee on undrawn amounts. This structure exposes the company to variable interest rates but avoids an upfront fee.
The agreement adds leverage and interest coverage covenants, requiring a Consolidated Leverage Ratio at or below 2.50:1 and Interest Coverage of at least 3.00:1 from the quarter ending March 31, 2026. These conditions can influence future borrowing capacity and capital allocation, but their impact will depend on how LifeMD’s earnings and debt levels evolve over time.
8-K Event Classification
FAQ
What did LifeMD (LFMD) disclose in this 8-K report?
LifeMD disclosed that it entered into a Credit Agreement with Citizens Bank for a senior secured revolving credit facility to support potential corporate development and shareholder value creation initiatives.
How large is LifeMDs new revolving credit facility with Citizens Bank?
The Credit Facility allows aggregate outstanding borrowings of up to $30 million, with the possibility to increase the principal amount by up to an additional $20 million on specified terms.
When does the LifeMD revolving credit facility mature?
The revolving Credit Facility has a stated maturity date of January 2, 2029.
What interest rates and fees apply under LifeMDs credit facility?
Outstanding borrowings bear a variable rate based on either Term SOFR plus 1.50%–2.25% or an Alternate Base Rate plus 0.50%–1.25%, with a commitment fee of 0.225%–0.30% on the average unused amount, depending on the Consolidated Leverage Ratio.
What financial covenants are included in the LifeMD Credit Agreement?
Beginning with the quarter ending March 31, 2026, LifeMD must maintain a Consolidated Leverage Ratio at or below 2.50 to 1.00 and a Consolidated Interest Coverage Ratio of at least 3.00 to 1.00.
Has LifeMD drawn any amounts under the new credit facility?
No. LifeMD had not drawn any funds under the Credit Facility as of the closing date of January 2, 2026.
What agreements provide collateral and support for LifeMDs credit facility?
In connection with the Credit Agreement, LifeMD and its subsidiaries entered into a revolving loan note, a pledge and security agreement, and a guarantee agreement to provide credit support for the facility.
AI-generated analysis. How Rhea-AI works. Not financial advice.
